ELVN - Balance Sheet - Enliven Therapeutics, Inc.

Current Liabilities	15.9 M
Accounts Payable	1.34 M
Short-Term Debt	0
Other Current Liabilities	14.6 M
Non-Current Liabilities	0
Long-Term Debt	0
Other Non-Current Liabilities	0

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017
ASSETS
Cash & Cash Equivalents	124.1	100.1	75.5	110.0	130.4	4.9	7.4	9.7
Short Term Investments	189.3	153.0	0	42.0	40.5	24.0	0	0
Receivables	0	0	0	0	0	0	0	0
Inventory	0	0	0	0	0	0	0	0
Other Current Assets	4.7	13.0	2.2	0.6	0.2	1.7	0.3	0.6
Total Current Assets	318.1	266.2	77.8	110.7	130.6	30.6	7.7	10.2
PP&E	0.5	1.1	1.5	1.0	0.4	0.4	0	0
Intangible Assets	0	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0	0
Long Term Investments	0	0	54 K	0.2	88 K	88 K	0	0
Other Long Term Assets	7.2	4.7	4.0	1.5	88 K	2.1	0	0
Other Assets	0	0	0	0	0	0	0	0
Total Assets	325.8	271.9	83.3	113.3	131.0	33.3	7.7	10.2
LIABILITIES
Accounts Payable	1.3	0.5	3.4	2.5	0.8	1.7	0.9	0.4
Short Term Debt	0	0.3	0.3	0.2	0.1	0	0	0
Other Current Liabilities	14.6	25.0	6.0	3.1	0.6	2.5	0.9	0.4
Total Current Liabilities	15.9	25.9	9.7	5.8	1.5	4.2	1.8	0.8
Long Term Debt	0	0	0	0	0	0	0	0.7
Deferred Tax Income	0	0	0	0	0	0	0	0
Other Liabilities	0	67 K	150.4	150.5	149.8	0.2	32.2	0
Total Liabilities	15.9	26.0	160.1	156.2	151.3	4.4	1.8	1.5
EQUITY
Common Stock	49 K	41 K	1 K	1 K	1 K	4 K	4 K	4 K
Retained Earnings	(243.5)	(154.4)	(82.9)	(45.2)	(20.5)	(54.8)	(31.3)	(20.0)
Other Accumulative Comprehensive Income/Loss	55 K	0.1	(0.1)	16 K	4 K	32 K	0	0
Total Equity	309.8	245.9	(76.8)	(42.9)	(20.3)	(48.8)	(26.3)	(15.5)
Total Liabilities and Equity	325.8	271.9	83.3	113.3	131.0	33.3	7.7	10.2
SHARES OUTSTANDING
Common Shares Outstanding	47.1	35.5	6.2	7.8	3.5	4.3	4.3	4.3

Free